Happy President’s Day
Happy President’s Day!
I hope that each of you has had a wonderful holiday. A massive thank you to all of those in healthcare who are still working on the holiday.
I thought this quote from…
Tag: STI
HIStalk Interviews Sachin Agrawal, CEO, EVisit
Sachin Agrawal, MSc is CEO of EVisit of Mesa, AZ.
Tell me about yourself and the company.
I’ve been in healthcare consulting and software for 20 years, always focused on the enterprise needs…
Zero Trust Offers a Foundation for Authentication and Access in Healthcare
Zero Trust and NIST SP 800-207The National Institutes of Standards and Technology brought private and public partnerships together to discuss how to develop a framework to defend against attacks. On Aug. 11, 2020, NIST…
Continue Reading
Q&A: Utilizing robotics and predictive analytics to transform care
The COVID-19 pandemic accelerated digital transformation within healthcare, becoming a strategic part of improving care.As a preview of his HIMSS23 presentation, Dr. Jong Soo Choi, information technology lead at Samsung Medical Center, discussed SMC’s embedded technology with MobiHealthNews via email.
MobiHealthNews: How has Samsung Medical Center shifted its technology use over time?
Dr. Jong…
Business Intelligence in Healthcare: A Comprehensive Guide
Harness the true power of the data!
Yes. That’s the ultimate goal of Business intelligence (BI).
BI has the potential to unlock endless possibilities for the healthcare industry to thrive.
In other words, data is evolving as a new diagnostic tool in healthcare.
That’s the reason, healthcare organizations, startups, enterprises, and individuals are…
Raman-Based Urine Sensor Detects Cancer Metabolites
Researchers at the Korea Institute of Materials Science (KIMS) creaetd a Raman-spectroscopy-based urine test that can detect metabolic compounds that are produced by pancreatic and prostate cancers, potentially allowing for rapid and convenient cancer screening. The technology consists of a paper strip onto which a urine sample can be added. The…
Continue Reading
ChatGPT Asks the Questions – Healthcare IT Today Podcast Episode 108
For the 108th episode of the Healthcare IT Podcast, we decided to mix things up. Regular listeners will know that last episode we talked about Generative AI (ChatGPT being one example) in healthcare. With that context in mind, we thought it would be fun for this episode to let ChatGPT take…
Continue Reading
NIST selects Ascon for new lightweight cryptography standard
The National Institute of Standards and Technology says it will publish the Ascon group of algorithms in its lightweight cryptography standard later this year.WHY IT MATTERS
NIST has found “a worthy defender” of data generated by small Internet of Things-connected devices as the result of a four-year international competition, according to the…
Lunit opens European unit to hasten expansion
South Korean medical AI company Lunit has announced its decision to establish a wholly-owned subsidiary in Europe.According to a press release, Lunit Europe Holdings will be based in Amsterdam in the Netherlands and will begin local staff recruitment shortly.
WHY IT MATTERS
Although Lunit had a branch office which previously managed its European business, its subsidiary in the continent will allow it to plan for the expansion of its sales network and fortify existing partnerships there.
According to data from Statista, the European medical device market is expected to be worth $136 billion this year. Its biggest segment is cardiology devices with a projected…
5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials
Melissa Mooney, Director of eCOA Solutions Engineering at IQVIAIn the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the side effects are tolerable for patients and how these treatments could be improved from the patient’s…
Continue Reading